Tyrosine kinase 2 inhibitor (Myrobalan Therapeutics)

N/A

Report date: 2024/03/08 14:48:43
NME

Base Information

Drug NameTyrosine kinase 2 inhibitor (Myrobalan Therapeutics)
Drug Alias NameTYK2 inhibitor (Myrobalan Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMyrobalan Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMyrobalan Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson DiseaseMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A